Variant position: 138 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 382 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TDGVNVDMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Mouse TDGVNVEMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Rat TDGVNVEMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Pig TDGVNVEMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Bovine TDGANVDMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Rabbit TDGVNVEMHLKQIEIKKFKY GIEEHGKVKMRGGLLRTYIIS
Chicken NDGVNVDMHLKQIESKKFKY GIEEHGKVKMRGGLLRTYIIS
Xenopus laevis NEGGNVDMHLKQIEIKKFKY GLEEHGKVKMRGGLLRTYIIS
Zebrafish NDGGDVELHLKKIELKKFKH GLEEHGKVKMKGSLLRTYIFS
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 382 Gap junction alpha-1 protein
100 – 154 Cytoplasmic
54 – 192
144 – 144 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia.
Paznekas W.A.; Boyadjiev S.A.; Shapiro R.E.; Daniels O.; Wollnik B.; Keegan C.E.; Innis J.W.; Dinulos M.B.; Christian C.; Hannibal M.C.; Jabs E.W.;
Am. J. Hum. Genet. 72:408-418(2003)
Cited for: NON-ASSOCIATION WITH NON-SYNDROMIC AUTOSOMAL RECESSIVE DEAFNESS; VARIANTS ODDD SER-17; PRO-18; ARG-21; GLU-22; THR-23; VAL-40; LYS-49; PHE-52 INS; SER-76; VAL-90; CYS-98; ASN-102; THR-130; GLU-134; ARG-138; HIS-202 AND LEU-216; VARIANT VAL-253;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.